Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-025070)

Filing Details

Accession Number:: 0000899243-21-025070
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-21 18:20:58
Reporting Period:: 2021-06-17

Accepted Time:: 2021-06-21 18:20:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840574	Verve Therapeutics Inc.	VERV	Pharmaceutical Preparations (2834)	824800132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1864112	Sekar Kathiresan	C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-21	2,500	$19.00	406,536	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2021-06-17	53,998	$0.00	53,998	$19.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
53,998		2031-06-16	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	80,997	Indirect	Kathiresan Family 2021 Irrevocable Trust
Common Stock	80,997	Indirect	Sekar Kathiresan 2021 Irrevocable Trust

Footnotes

The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 17, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 17, 2025.